FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1592764712> ?p ?o ?g. }

• W1592764712 abstract "ON01910.Na (Rigosertib, Estybon®), a styryl benzylsulfone, is a Phase III stage anti-cancer agent. This non-ATP competitive kinase inhibitor has multi-targeted activity, promoting mitotic arrest and apoptosis. Extensive Phase I/II studies with ON01910.Na, conducted in patients with solid tumours and haematological cancers demonstrate excellent efficacy. However, issues remain affecting its development. These include incomplete understanding of anti-tumour mechanisms, low oral bioavailability and unpredictable pharmacokinetics. In an attempt to improve drug-likeness and ADME properties of ON01910.Na analogues, a novel series of (E)-styrylsulfonyl methylpyridine derivatives was designed and synthesised. The SAR of this novel series is discussed. The lead compounds TL-68, TL-77, and AH-123 are highly potent mitotic inhibitors. Their selective cytotoxicity to cancer cells was identified in the screening cascade. Impressively, TL-77 possesses excellent pharmaceutical properties, with improved oral bioavailability when compared to ON01910.Na.The detailed cellular mechanisms of TL-77 were further investigated in comparison with ON01910.Na. TL-77 exhibits potent anti-proliferative activity against a wide range of human tumour cell lines, and demonstrated > 2 fold greater potency in cancer cell lines over normal cells.. Cell cycle analyses reveal that TL-77 evokes profound G2/M cell cycle arrest at ≥ 6 h in cancer cells, followed by the onset of apoptosis. In cell-free conditions, TL-77 as well as ON01910.Na potently inhibits tubulin polymerization. Mitotically arrested cells display multipolar spindles and misalignment of chromosomes, indicating TL-77 interfere mitotic spindle assembly in cancer cells. These effects are accompanied by induction of DNA damage, inhibition of Cdc25c (Ser198) phosphorylation [indicative polo-like kinase 1 (Plk1) inhibition], and downstream inhibition of cyclin B1. However, kinase assays failed to confirm the inhibition of Plk1. Non-significant effects on PI3K/AKT signal transduction are observed after TL-77 treatment. Analysis of apoptotic signalling pathways reveals that TL-77 down-regulates expression of B-cell lymphoma 2 (Bcl-2) family proteins [Bid (BH3 interacting-domain death agonist), Bcl-xl (B-cell lymphoma-extra large) and Mcl-1 (induced myeloid leukaemia cell differentiation protein)] and stimulates caspase activation. These effects are comparable to those elicited by ON01910.Na. Unlike ON01910.Na, however, TL-77 causes preferential toxicity in cancer cells when compared to normal cells and mediates rapid mitotic inhibitory effects.In summary, selective in vitro anti-tumour activity and multi-faceted mechanisms of action of a novel molecule TL-77 have been identified, presenting a strong rationale for further development of (E)-styrylsulfonyl methylpyridine derivatives as therapeutic agents for cancer." @default.
• W1592764712 created "2016-06-24" @default.
• W1592764712 creator A5081647429 @default.
• W1592764712 date "2014-12-09" @default.
• W1592764712 modified "2023-09-22" @default.
• W1592764712 title "Synthesis and biological evaluation of novel anti-tumour (E)-styrylsulfonyl methylpyridines" @default.
• W1592764712 cites W1500036797 @default.
• W1592764712 cites W1500847299 @default.
• W1592764712 cites W1517051009 @default.
• W1592764712 cites W1545398558 @default.
• W1592764712 cites W1574601694 @default.
• W1592764712 cites W1591187753 @default.
• W1592764712 cites W1924895133 @default.
• W1592764712 cites W1926612287 @default.
• W1592764712 cites W1933723496 @default.
• W1592764712 cites W1942214720 @default.
• W1592764712 cites W1965008416 @default.
• W1592764712 cites W1966827520 @default.
• W1592764712 cites W1968091681 @default.
• W1592764712 cites W1968868084 @default.
• W1592764712 cites W1971476329 @default.
• W1592764712 cites W1972161591 @default.
• W1592764712 cites W1973247925 @default.
• W1592764712 cites W1974238141 @default.
• W1592764712 cites W1975776530 @default.
• W1592764712 cites W1975947882 @default.
• W1592764712 cites W1976023782 @default.
• W1592764712 cites W1979976148 @default.
• W1592764712 cites W1981711832 @default.
• W1592764712 cites W1984264526 @default.
• W1592764712 cites W1986005454 @default.
• W1592764712 cites W1987861755 @default.
• W1592764712 cites W1988050012 @default.
• W1592764712 cites W1990511694 @default.
• W1592764712 cites W1992708996 @default.
• W1592764712 cites W1992844265 @default.
• W1592764712 cites W1993771588 @default.
• W1592764712 cites W1995719471 @default.
• W1592764712 cites W1997510628 @default.
• W1592764712 cites W1998836974 @default.
• W1592764712 cites W2001108774 @default.
• W1592764712 cites W2001443196 @default.
• W1592764712 cites W2002475826 @default.
• W1592764712 cites W2003494512 @default.
• W1592764712 cites W2009947878 @default.
• W1592764712 cites W2012173926 @default.
• W1592764712 cites W2012949016 @default.
• W1592764712 cites W2014080346 @default.
• W1592764712 cites W2015507005 @default.
• W1592764712 cites W2015894551 @default.
• W1592764712 cites W2017181626 @default.
• W1592764712 cites W2017227682 @default.
• W1592764712 cites W2018116689 @default.
• W1592764712 cites W2018616835 @default.
• W1592764712 cites W2020246613 @default.
• W1592764712 cites W2020411912 @default.
• W1592764712 cites W2020700496 @default.
• W1592764712 cites W2021246859 @default.
• W1592764712 cites W2021505095 @default.
• W1592764712 cites W2022803736 @default.
• W1592764712 cites W2024611216 @default.
• W1592764712 cites W2024668312 @default.
• W1592764712 cites W2025540821 @default.
• W1592764712 cites W2027235240 @default.
• W1592764712 cites W2029108033 @default.
• W1592764712 cites W2030205108 @default.
• W1592764712 cites W2034269086 @default.
• W1592764712 cites W2034825883 @default.
• W1592764712 cites W2035258932 @default.
• W1592764712 cites W2037674800 @default.
• W1592764712 cites W2037874673 @default.
• W1592764712 cites W2040082111 @default.
• W1592764712 cites W2043794217 @default.
• W1592764712 cites W2044195791 @default.
• W1592764712 cites W2044387885 @default.
• W1592764712 cites W2048109276 @default.
• W1592764712 cites W2048174395 @default.
• W1592764712 cites W2048551141 @default.
• W1592764712 cites W2048938594 @default.
• W1592764712 cites W2049112891 @default.
• W1592764712 cites W2049613540 @default.
• W1592764712 cites W2050156567 @default.
• W1592764712 cites W2053418752 @default.
• W1592764712 cites W2054917860 @default.
• W1592764712 cites W2056998713 @default.
• W1592764712 cites W2058564277 @default.
• W1592764712 cites W2059244275 @default.
• W1592764712 cites W2059409197 @default.
• W1592764712 cites W2059706603 @default.
• W1592764712 cites W2060346337 @default.
• W1592764712 cites W2062265555 @default.
• W1592764712 cites W2063461424 @default.
• W1592764712 cites W2063953032 @default.
• W1592764712 cites W2068384749 @default.
• W1592764712 cites W2070873632 @default.
• W1592764712 cites W2072451938 @default.
• W1592764712 cites W2076183717 @default.
• W1592764712 cites W2078049733 @default.
• W1592764712 cites W2078532650 @default.
• W1592764712 cites W2079398727 @default.

• next